EDX Medical Group

EDX Medical Group Quick Ratio

The Quick Ratio (Acid Test) of EDX Medical Group (EDX.AQ) as of Nov 5, 2026 is 3.32. In the previous year, Quick Ratio (Acid Test) was 2.50 — a change of 32.55% (higher).

Quick Ratio

3.32

YoY

32.55%

Last updated:

Quick Ratio (Acid Test) of EDX Medical Group is 2025 3.32 . Quick Ratio (Acid Test) of EDX Medical Group was 2024 2.50 . It decreases by 32.55% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EDX Medical Group Stock analysis

What does EDX Medical Group do? EDX Medical Group Plc generates revenue through the sale of digitally enabled diagnostic products and services to individuals and organizations. The company offers point-of-care, home, and workplace testing tools that allow personalized diagnosis according to international standards. Its disease surveillance solutions are sold to cross-border agencies and governments for identifying new disease variants with high transmission risks. The firm also partners with researchers and clinicians to commercialize their discoveries into marketable products. The primary buyers of EDX Medical Group's diagnostic tools include healthcare professionals, individuals seeking personal health monitoring, and government agencies responsible for public health surveillance. Cross-border agencies utilize the disease surveillance solutions to track rapidly spreading variants. Researchers and clinicians form strategic partnerships to develop and launch new diagnostic products through the company's platform. EDX Medical Group's product portfolio consists of diagnostic tests for point-of-care, home, and workplace use, alongside disease surveillance systems. The company's services focus on enabling personalized medical diagnosis and early detection of disease variants. Revenue streams are derived from direct sales of diagnostic tools, government contracts for surveillance systems, and partnership agreements with research institutions. EDX Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EDX Medical Group stock

Quick Ratio (Acid Test) of EDX Medical Group is 3.32 in 2025.

Quick Ratio (Acid Test) of EDX Medical Group changed from 2.50 to 3.32, representing a 32.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) EDX Medical Group since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s EDX Medical Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — EDX Medical Group

All Key Metrics — EDX Medical Group